Article Text

Download PDFPDF
Randomised controlled trial
Large placebo-controlled RCT in myocardial infarction survivors finds that daily folic acid and vitamin B12 have no effect on risk of major vascular event
  1. Alessandro Pezzini
  1. Dipartimento di Scienze Mediche e Chirurgiche, Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italia
  1. Correspondence to Alessandro Pezzini
    P.le Spedali Civili, 1, 25100 Brescia, Italia; ale_pezzini{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on:


Convincing experimental evidence indicates a causal relationship between increased plasma levels of total homocysteine (tHcy), endothelial cell dysfunction and accelerated atherosclerosis. However, if this appears to be true for markedly elevated tHcy concentrations, such as those observed in rare inborn disorders of methionine metabolism, it is still controversial as to whether or not moderately elevated tHcy levels contribute independently to increased cardiovascular risk. Some observational studies support this view, whereas others did not find any effect or only in specific subgroups of patients. The best method to answer the question of the causal relationship between homocysteine (Hcy) and cardiovascular disease is to randomise patients at high vascular risk to placebo or Hcy-lowering multivitamin therapy and follow them prospectively for the occurrence of atherothrombotic events. Unfortunately, most of the intervention trials conducted so far have insufficient statistical power to provide conclusive results. …

View Full Text


  • Competing interests None.